BioAge Labs, Inc (BIOA) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $22.32
• Market Cap: $924.40M
• P/E Ratio: 1.63
• EPS: $13.61
• 52-Week High: $24.00
• 52-Week Low: $2.88

Market Sentiment

BioAge Labs, Inc currently has a Bullish sentiment score of 0.44.

About BioAge Labs, Inc

BioAge Labs, Inc. is a forward-thinking biotechnology company based in Montreal, Canada, dedicated to advancing healthspan and longevity through groundbreaking aging research. By leveraging insights from the biology of aging, BioAge focuses on the discovery and validation of therapeutics targeting age-related diseases, positioning itself as a leader in the transformative landscape of geriatric healthcare. With a commitment to scientific excellence and collaboration with premier research insti...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for BioAge Labs, Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BIOA pay dividends?

BioAge Labs, Inc (BIOA) does not currently pay a regular dividend.

What is BIOA's P/E ratio?

BioAge Labs, Inc has a price-to-earnings (P/E) ratio of 1.63.

What is BIOA's market cap?

BioAge Labs, Inc (BIOA) has a market capitalization of $924.40M with a current stock price of $22.32.